US wants ingredient in swine flu vaccine by May

April 28, 2009 By LAURAN NEERGAARD , AP Medical Writer

(AP) -- U.S. scientists hope to have a key ingredient for a swine flu vaccine ready in early May, but tell The Associated Press that the novel virus grows slowly in eggs - the chief way flu vaccines are made.

Even if all goes well, it still will take months before any shots are available for the necessary safety testing in volunteers.

Dr. Jesse Goodman, the Food and Drug Administration's swine flu chief, said Tuesday that scientists are working, in his words, "at 100 miles an hour" to create good raw material to deliver to manufacturers.

The researchers must engineer a strain that could trigger the without causing illness. At the Centers for Disease Control and Prevention, chief Dr. Ruben Donis says that work is about a third completed.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Related Stories

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.